Statins for Treatment of Primary Intracerebral Hemorrhage

Summary

The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.

Timeline

Start

2023-05-06

Primary completion

2026-09-30

Completion

2026-12-31

Drugs

Indications